Biotage AB (publ) (BIOT.ST)
SEK 141.1
(0.21%)
SEK 141.1
(0.21%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 150 Million SEK | -21.88% |
| 2022 | 192 Million SEK | 6.67% |
| 2021 | 180 Million SEK | -5.99% |
| 2020 | 191.47 Million SEK | -11.53% |
| 2019 | 216.42 Million SEK | 95.68% |
| 2018 | 110.6 Million SEK | 16759.91% |
| 2017 | 656 Thousand SEK | -19.51% |
| 2016 | 815 Thousand SEK | -24.19% |
| 2015 | 1.07 Million SEK | -88.81% |
| 2014 | 9.6 Million SEK | -60.76% |
| 2013 | 24.48 Million SEK | -11.81% |
| 2012 | 27.76 Million SEK | 374.63% |
| 2011 | 5.85 Million SEK | -8.61% |
| 2010 | 6.4 Million SEK | 0.0% |
| 2009 | - SEK | -100.0% |
| 2008 | 8.06 Million SEK | -78.29% |
| 2007 | 37.15 Million SEK | -20.63% |
| 2006 | 46.8 Million SEK | -15.55% |
| 2005 | 55.42 Million SEK | 59.89% |
| 2004 | 34.66 Million SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 150 Million SEK | -48.81% |
| 2024 Q1 | 293 Million SEK | -1.35% |
| 2024 Q3 | 150 Million SEK | 0.0% |
| 2023 Q3 | 378 Million SEK | 7.39% |
| 2023 FY | 297 Million SEK | 54.69% |
| 2023 Q4 | 297 Million SEK | -21.43% |
| 2023 Q2 | 352 Million SEK | 79.59% |
| 2023 Q1 | 196 Million SEK | 2.08% |
| 2022 Q3 | 227 Million SEK | 2.71% |
| 2022 Q4 | 192 Million SEK | -15.42% |
| 2022 Q1 | 221 Million SEK | 22.78% |
| 2022 FY | 192 Million SEK | 6.67% |
| 2022 Q2 | 221 Million SEK | 0.0% |
| 2021 Q3 | 84 Million SEK | -3.2% |
| 2021 FY | 180 Million SEK | -5.99% |
| 2021 Q1 | 207.97 Million SEK | 8.62% |
| 2021 Q2 | 86.77 Million SEK | -58.28% |
| 2021 Q4 | 180 Million SEK | 114.29% |
| 2020 Q3 | 202.4 Million SEK | -1.7% |
| 2020 Q2 | 205.9 Million SEK | -12.71% |
| 2020 FY | 191.47 Million SEK | -11.53% |
| 2020 Q1 | 235.88 Million SEK | 8.99% |
| 2020 Q4 | 191.47 Million SEK | -5.4% |
| 2019 Q2 | 263.99 Million SEK | 16.98% |
| 2019 FY | 216.42 Million SEK | 95.68% |
| 2019 Q4 | 216.42 Million SEK | -2.08% |
| 2019 Q1 | 225.66 Million SEK | 104.04% |
| 2019 Q3 | 221.02 Million SEK | -16.28% |
| 2018 Q1 | 109.94 Million SEK | 16659.3% |
| 2018 Q4 | 110.6 Million SEK | 0.61% |
| 2018 FY | 110.6 Million SEK | 16759.91% |
| 2018 Q3 | 109.92 Million SEK | -0.01% |
| 2018 Q2 | 109.93 Million SEK | -0.0% |
| 2017 Q1 | 773 Thousand SEK | -5.15% |
| 2017 Q4 | 656 Thousand SEK | -3.39% |
| 2017 Q3 | 679 Thousand SEK | -6.6% |
| 2017 FY | 656 Thousand SEK | -19.51% |
| 2017 Q2 | 727 Thousand SEK | -5.95% |
| 2016 Q4 | 815 Thousand SEK | -5.89% |
| 2016 Q2 | 910 Thousand SEK | -6.57% |
| 2016 Q1 | 974 Thousand SEK | -9.4% |
| 2016 FY | 815 Thousand SEK | -24.19% |
| 2016 Q3 | 866 Thousand SEK | -4.84% |
| 2015 Q4 | 1.07 Million SEK | -79.04% |
| 2015 FY | 1.07 Million SEK | -88.81% |
| 2015 Q1 | 9.49 Million SEK | -1.18% |
| 2015 Q3 | 5.12 Million SEK | -6.15% |
| 2015 Q2 | 5.46 Million SEK | -42.46% |
| 2014 Q1 | 25.66 Million SEK | 4.79% |
| 2014 Q2 | 19.37 Million SEK | -24.51% |
| 2014 Q4 | 9.6 Million SEK | -49.9% |
| 2014 FY | 9.6 Million SEK | -60.76% |
| 2014 Q3 | 19.17 Million SEK | -1.0% |
| 2013 Q2 | 5.47 Million SEK | 17.0% |
| 2013 Q3 | 5.25 Million SEK | -3.95% |
| 2013 FY | 24.48 Million SEK | -11.81% |
| 2013 Q4 | 24.48 Million SEK | 365.98% |
| 2013 Q1 | 4.67 Million SEK | -83.16% |
| 2012 Q4 | 27.76 Million SEK | 420.06% |
| 2012 Q1 | 5.65 Million SEK | -3.37% |
| 2012 Q2 | 5.64 Million SEK | -0.11% |
| 2012 FY | 27.76 Million SEK | 374.63% |
| 2012 Q3 | 5.33 Million SEK | -5.45% |
| 2011 Q2 | 5.86 Million SEK | -2.75% |
| 2011 FY | 5.85 Million SEK | -8.61% |
| 2011 Q3 | 6 Million SEK | 2.44% |
| 2011 Q4 | 5.85 Million SEK | -2.56% |
| 2011 Q1 | 6.02 Million SEK | -5.84% |
| 2010 Q4 | 6.4 Million SEK | -4.23% |
| 2010 Q3 | 6.68 Million SEK | -10.06% |
| 2010 Q2 | 7.43 Million SEK | 4.69% |
| 2010 FY | 6.4 Million SEK | 0.0% |
| 2010 Q1 | 7.09 Million SEK | 0.0% |
| 2009 Q4 | - SEK | 0.0% |
| 2009 FY | - SEK | -100.0% |
| 2008 FY | 8.06 Million SEK | -78.29% |
| 2007 FY | 37.15 Million SEK | -20.63% |
| 2006 FY | 46.8 Million SEK | -15.55% |
| 2005 FY | 55.42 Million SEK | 59.89% |
| 2004 FY | 34.66 Million SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AddLife AB (publ) | 2.53 Billion SEK | 94.092% |
| Bonesupport Holding AB (publ) | 13.22 Million SEK | -1034.473% |
| Doxa AB (publ) | 3.6 Million SEK | -4066.667% |
| Elekta AB (publ) | 4.8 Billion SEK | 96.88% |
| iZafe Group AB (publ) | 279 Thousand SEK | -53663.441% |
| Ortivus AB (publ) | 3.57 Million SEK | -4096.978% |
| Ortivus AB (publ) | 3.57 Million SEK | -4096.978% |
| Q-linea AB (publ) | 12.9 Million SEK | -1062.34% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 2.02 Billion SEK | 92.607% |